from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0463/-

LFCtreatmentdescriptionclass of inhibitor

-0.322

Amikacinug/mL Amikacintranslation

-1.320

Cap5-10ug/mL Capreomycintranslation

-0.557

Rox10-50 ug/mL Roxithromycintranslation

0.705

SM2-5 ug/mL Streptomycintranslation

-0.771

Tet5-10 ug/mL Tetracyclinetranslation

-1.638

Rif0.2-5ug/mL Rifampicintranscription

-2.237

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.075

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.107

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.286

CPZ10-50 ug/mL Chlorpromazinerespiration

0.617

Clofazimine10-13 ug/mL Clofaziminerespiration

0.544

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.577

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.215

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.409

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.124

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.181

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.708

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.986

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.040

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.542

KCN5-20 ug/mL Potassium cyaniderespiration

0.093

NaN30.2-2 mM Sodium aziderespiration

0.561

Nigericin50 uM Nigericinrespiration

-0.916

TRC10-150 ug/mL Triclosanrespiration

0.793

TRZ10-25 ug/mL Thioridazinerespiration

-0.687

Valinomycin0.5-10 uM Valinomycinrespiration

-0.056

ZnSO42 mM ZnSO4respiration

-0.222

menadione6-10 ug/mL Menadionerespiration

0.212

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.007

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.132

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.073

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.222

NRP_1Non-replicating persistence stage 1dosRassociated

0.144

Amp0.2mg/mL AmpicillincellWall

0.322

Cephalexin20-100 ug/mL CephalexincellWall

-0.166

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.325

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.473

EMB10-20 ug/mL EthambutolcellWall

0.709

Eta12-40 ug/mL EthionamidecellWall

1.302

INH0.2-0.4 ug/mL IsoniazidcellWall

0.244

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.133

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.091

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.768

BZA0.12 mg/mL BenzamidearomaticAmides

-0.660

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.903

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.096

H2O24 mM hydrogen peroxideDNAdamaging

-1.230

Levo10 ug/mL LevofloxacinDNAdamaging

-0.476

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.919

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.085

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.388

UVUV-irradiationDNAdamaging

1.970

ARP41-4 ug/mL Antitubercular compound ARP4?

0.337

Antimycin12.5-50 ug/mL Antimycin A?

-0.149

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.278

PA_110-50 ug/mL Antitubercular compound PA-1?

0.085

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.158

PA8240.2-2 ug/mL PA-824?

0.690

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.947

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.390

Verapamil50 uM Verapamil?

-0.377

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.255

methoxatin10-20 ug/mL Methoxatin?